ACSL3 expression and activity in lung cancer cells is upregulated by mutant KRAS
ACSL3 suppression decreases β-oxidation and ATP levels in mutant KRAS lung cancer cells
ACSL3 is required for survival and oncogenic capacity of mutant KRAS lung cancer cells
ACSL3 is highly expressed in human lung cancer specimens and promotes cancer initiation